Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The loss of estrogen and progesterone receptor gene expression in human breast cancer.

Journal of mammary gland biology and neoplasia - 1 Jan 1998

Lapidus R G, Nass S J, Davidson N E

Abstract excerpt

Hormone responsiveness is a critical determinant of breast cancer progression and management, and the response to endocrine therapy is highly correlated with the estrogen receptor (ER)3 and progesterone receptor (PR) status of tumor cells. Thus, key areas of study in breast cancer are those mechanisms that regulate ER and PR expression in normal and malignant breast tissues. One-third of all breast cancers lack...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to DNA Methylation
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Source

Identifiers

PMID: 10819507
DOI: 10.1023/a:1018778403001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The loss of estrogen and progesterone receptor gene expression in human breast cancer.PMID 10819507Read ↗

Genetic and epigenetic alterations of the estrogen receptor gene and hormone independence in human breast cancer.Semantic proximity Read ↗

The genomic landscape of HER2 negative metastatic breast cancer with loss of estrogen and progesterone receptors.Semantic proximity Read ↗

Molecular Changes During Breast Cancer and Mechanisms of Endocrine Therapy Resistance.Semantic proximity Read ↗

Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signalingSemantic proximity Read ↗

Estrogen receptors: new perspectives in breast cancer management.Semantic proximity Read ↗

Mechanisms for estrogen receptor expression in human cancerSemantic proximity Read ↗

The regulation of estrogen receptor expression and function in human breast cancer.Semantic proximity Read ↗

Modulation of estrogen receptor alpha activity and expression during breast cancer progression.Semantic proximity Read ↗

Unliganded Progesterone Receptor Governs Estrogen Receptor Gene Expression by Regulating DNA Methylation in Breast Cancer CellsSemantic proximity Read ↗

Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goalsSemantic proximity Read ↗

Emerging functional roles of nuclear receptors in breast cancerSemantic proximity Read ↗

Mechanisms of hormone resistance in breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.